ArticleFrontiers in oncology2019
Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma.
Mengjie Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleFrontiers in oncology2019
Mengjie Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.